Literature DB >> 18674946

Efficacy of anakinra in a patient with refractory relapsing polychondritis.

Daniel Wendling, Sophie Govindaraju, Clément Prati, Eric Toussirot, Ewa Bertolini.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18674946     DOI: 10.1016/j.jbspin.2008.02.011

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN: 1297-319X            Impact factor:   4.929


× No keyword cloud information.
  7 in total

1.  Relapsing polychondritis: new therapeutic strategies with biological agents.

Authors:  Paola Sabrina Buonuomo; Claudia Bracaglia; Andrea Campana; Maya El Hachem; Andrea Diociaiuti; Antonella Insalaco; Fabrizio De Benedetti; Beatrice Chiarini Testa; Elisabetta Cortis; Giovanni Carlo De Vincentiis; Alberto G Ugazio
Journal:  Rheumatol Int       Date:  2009-08-15       Impact factor: 2.631

2.  [Recommendations on therapy using interleukin-1beta-blocking agents].

Authors:  B Manger; M Gaubitz; H Michels
Journal:  Z Rheumatol       Date:  2009-11       Impact factor: 1.372

Review 3.  The NLRP3 inflammasome in health and disease: the good, the bad and the ugly.

Authors:  P Menu; J E Vince
Journal:  Clin Exp Immunol       Date:  2011-07-15       Impact factor: 4.330

Review 4.  Relapsing polychondritis: a chameleon among orphan diseases.

Authors:  Sabine Schumacher; Herwig Pieringer
Journal:  Wien Med Wochenschr       Date:  2017-03-31

5.  [IL-1 antagonists].

Authors:  I Kötter; G Horneff
Journal:  Z Rheumatol       Date:  2010-09       Impact factor: 1.372

Review 6.  Interleukin-1 antagonists in the treatment of autoinflammatory syndromes, including cryopyrin-associated periodic syndrome.

Authors:  Pierre Quartier
Journal:  Open Access Rheumatol       Date:  2011-01-18

Review 7.  Relapsing Polychondritis: An Updated Review.

Authors:  Francesco Borgia; Roberta Giuffrida; Fabrizio Guarneri; Serafinella P Cannavò
Journal:  Biomedicines       Date:  2018-08-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.